TY - JOUR T1 - Fetal supraventricular tachycardia, treating the baby by targeting the mother. AU - Husain,Aysha, AU - Hubail,Zakariya, AU - Al Banna,Rashed, Y1 - 2013/04/15/ PY - 2013/4/18/entrez PY - 2013/4/18/pubmed PY - 2013/12/25/medline JF - BMJ case reports JO - BMJ Case Rep VL - 2013 N2 - Fetal supraventricular tachycardia (SVT) is the most common form of fetal tachycardia. If started early in pregnancy, it can cause non-immune fetal hydrops. Echocardiography is the preferred method for the diagnosis with simultaneous pulsed Doppler recording from the superior vena cava and ascending aorta. Transplacental therapy with digoxin is the most common way of treatment. We present a case of fetal SVT detected at 26 weeks of pregnancy. Digoxin therapy restored the rhythm initially, but later paroxysms of fetal SVT persisted necessitating the addition of second antiarrhythmic medication which was discussed with the parents. The couple chose to proceed for premature delivery at 32 weeks. SN - 1757-790X UR - https://www.unboundmedicine.com/medline/citation/23592812/Fetal_supraventricular_tachycardia_treating_the_baby_by_targeting_the_mother_ L2 - https://casereports.bmj.com/lookup/pmidlookup?view=long&pmid=23592812 DB - PRIME DP - Unbound Medicine ER -